Sang Eun Ha Selected Research

Neoplasms (Cancer)

1/2022	Investigation on the cellular mechanism of Prunetin evidenced through next generation sequencing and bioinformatic approaches against gastric cancer.
1/2022	Structural and Functional Properties of Activator Protein-1 in Cancer and Inflammation.
8/2021	Inhibition of Cell Proliferation and Metastasis by Scutellarein Regulating PI3K/Akt/NF-κB Signaling through PTEN Activation in Hepatocellular Carcinoma.
5/2021	Transcriptome analysis of sinensetin-treated liver cancer cells guided by biological network analysis.
12/2020	Functions of polyphenols and its anticancer properties in biomedical research: a narrative review.
8/2020	Sinensetin Induces Autophagic Cell Death through p53-Related AMPK/mTOR Signaling in Hepatocellular Carcinoma HepG2 Cells.
1/2020	Naringin Induces Lysosomal Permeabilization and Autophagy Cell Death in AGS Gastric Cancer Cells.
1/2020	Apigetrin induces extrinsic apoptosis, autophagy and G2/M phase cell cycle arrest through PI3K/AKT/mTOR pathway in AGS human gastric cancer cell.
1/2020	Comparative proteomic analysis uncovers potential biomarkers involved in the anticancer effect of Scutellarein in human gastric cancer cells.
12/2018	Identification of a novel biomarker in tangeretin‑induced cell death in AGS human gastric cancer cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sang Eun Ha Research Topics

Disease

12	Neoplasms (Cancer) 01/2022 - 08/2018
9	Stomach Neoplasms (Stomach Cancer) 01/2022 - 08/2018
7	Inflammation (Inflammations) 06/2022 - 01/2019
3	Hepatocellular Carcinoma (Hepatoma) 08/2021 - 08/2020
2	Neoplasm Metastasis (Metastasis) 08/2021 - 12/2020
2	Sarcopenia 03/2021 - 10/2019
1	COVID-19 06/2022
1	Liver Neoplasms (Liver Cancer) 05/2021
1	Pneumonia (Pneumonitis) 01/2019

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 08/2021 - 10/2018
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2018
5	FlavonoidsIBA 05/2021 - 08/2018
4	Biological ProductsIBA 01/2022 - 04/2021
3	scutellareinIBA 06/2022 - 01/2020
3	sinensetinIBA 05/2021 - 10/2019
2	LipopolysaccharidesIBA 06/2022 - 03/2020
2	prunetinIBA 01/2022 - 01/2020
2	flavoneIBA 08/2021 - 01/2020
2	pectolinarigeninIBA 10/2018 - 08/2018
1	EndotoxinsIBA 06/2022
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 06/2022
1	CytokinesIBA 06/2022
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 06/2022
1	Mitogen-Activated Protein KinasesIBA 06/2022
1	PhytochemicalsIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2022
1	Galectin 4 (LGALS4)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 05/2021
1	QuercetinIBA 12/2020
1	CurcuminIBA 12/2020
1	PolyphenolsIBA 12/2020
1	ResveratrolIBA 12/2020
1	kaempferolIBA 12/2020
1	Peptides (Polypeptides)IBA 10/2020
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2020
1	naringinIBA 01/2020
1	Cyclin B1IBA 01/2020
1	apigetrinIBA 01/2020
1	MyogeninIBA 10/2019
1	Volatile Oils (Essential Oils)IBA 01/2019
1	Terpenes (Terpenoids)IBA 01/2019
1	tangeretinIBA 12/2018

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2020
1	Aftercare (After-Treatment) 08/2021